Back to Journals » OncoTargets and Therapy » Volume 16

Single-Center Retrospective Clinical Evaluation of Venetoclax Combined with HMAs and Half-Dose CAG for Unfit or Refractory/Relapsed AML

Total article views   HTML views PDF downloads Totals
3,000 Dovepress* 2,810+ 90 2,900
PubMed Central* 190 83 273
Totals 3,000 173 3,173
*Since 13 June 2023

View citations on PubMed Central and Google Scholar